3M0ller M, Andersen G, Gjedde A. Serotonin 5-HT1A receptoravailability and pathological crying after strokefj]. Acta NeurolScand, 2007, 116(2):83-90.
4Yi ZM, Liu F, Zhai SD, et al. Fluoxetine for the prophylaxis ofpoststroke depression in patients with stroke: a meta-analysis[J].Int J Clin Pract, 2010, 64(9):1310-1317.
5Karaiskos D, Tzavellas E, Spengos K, et al. Duloxetine versuscitalopram and sertraline in the treatment of poststroke depres-sion, anxiety, and fatigue[J]. J Neuropsychiatry Clin Neurosci,2012, 24(3):349-353.
6Valentine GW, Sanacora G. Targeting glial physiology and gluta-mate cycling in the treatment of depression[JJ. Biochem Pharma-col, 2009, 78(5):431-439.
7Wang X, Li YH, Li MH, et al. Glutamate level detection by mag-netic resonance spectroscopy in patients with post-stroke depres-sion[J]. Eur Arch Psy Clin N, 2012, 262(1):33-38.
8Fang J, Cheng Q. Etiological mechanisms of post-stroke depres-sion: a review[J] . Neurol Res, 2009,31(9):904-909.
9Pascoe MC, Crewther SG, Carey LM,et al. Inflammation and de-pression: why poststroke depression may be the norm and not theexception[J]. Int J Stroke, 2011,6(2):128-135.
10Spalletta G, Bossu P, Ciaramella A, et al. The etiology ofpost-stroke depression : a review of the literature and a new hy-pothesis involving inflammatory cytokines[J]. Mol Psychiatry,2006, 11(11): 984-991.
